WebFeb 9, 2024 · Mass General Giving. February 9, 2024. Psychiatry. Ekaterina Malievskaia and George Goldsmith. As co-founders of COMPASS Pathways, a London-based … WebGeorge is a serial entrepreneur with significant experience in pharmaceutical regulation. George's early training and experience was a multi-disciplinary blending of cognitive psychology, clinical psychology and computer science.His first company, The Human Interface Group, was a pioneer in collaborative software and acquired by Lotus. …
George Goldsmith Talks About His Drug for Treating …
WebYesterday, COMPASS co-founders George Goldsmith and Dr ... (FDA) and has received Innovative Licensing and Access Pathway (ILAP) designation in the UK for treatment-resistant depression (TRD). We ... WebCOMPASS Pathways announces publication of phase 2b study of COMP360 psilocybin therapy for treatment-resistant depression in The New England Journal of Medicine. Read more about our Phase 2b … my image saves
George Goldsmith Talks About His Drug for Treating Depression
WebOct 23, 2024 · George Goldsmith, the CEO of Compass Pathways — the first psilocybin company to trade publicly in the US — insists that he's not in the psychedelics business. WebGoldsmith and his wife (a medical doctor) were drawn to studying psilocybin for treatment-resistant depression (TRD) because of a family medical crisis. Their son developed severe depression after starting … WebApr 30, 2024 · You can subscribe to this podcast from any podcast player by typing "After On" in the search window. If you're on an iPhone and use Apple's podcast software, just click here, If you're on a computer, click on that same link – then click the blue “View on iTunes” button (under the After On image on the left side of the page), then click … my images are not loading in wordpress